Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Armada Berjaya Trans Tbk (JAYA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Armada Berjaya Trans TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Armada Berjaya Trans Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Armada Berjaya Trans Tbk trades at Rp134 (market cap 106.2B, 1.89M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 6.1× Armada Berjaya Trans Tbk's market cap, and Armada Berjaya Trans Tbk is more actively traded (1.89M versus 848.2K). Which is the better fit depends on your goals.

JAYALABS
Market Cap
106.2B651.75B
Volume
1.89M848.2K
Lot
18.94K8.48K
Turnover
250.46M140.51M
Average Price
132.23165.66
Value
250.46M140.51M
Indicative Equilibrium Price
134168
Indicative Equilibrium Volume
31050

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JAYA
View details
LABS
View details

About Armada Berjaya Trans Tbk

PT Armada Berjaya Trans (“the Entity”) was established based on the Notarial Deed No. 41 dated May 30, 2012 of Myra Yuwono, S.H. The Articles of Assocation has been amended several times, and the latest changes are stated in the Notarial Deed of Christina Dwi Utami, S.H. No. 39 dated August 21, 2018, concerning in the change in the Entity’s name from PT Armada Beton to PT Armada Berjaya Trans. PT Armada Beton specialising in Cement Mixer transporter. Since 2015 the company shifted its focus into general land transport business.

Read more on JAYA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS